Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Mineralys Therapeutics, Inc. (MLYS) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-32.23M |
|
-- |
|
-- |
|
$38.28M |
|
$-38.28M |
|
$6.05M |
|
$-32.23M |
|
$-32.23M |
|
$-32.23M |
|
$-32.23M |
|
$-32.23M |
|
$-32.23M |
|
$-38.28M |
|
$-38.27M |
|
67.66M |
|
67.66M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$661.39M |
|
$0.04M |
|
$0.42M |
|
$661.81M |
|
$15.11M |
|
-- |
|
-- |
|
$15.11M |
|
$646.69M |
|
$646.69M |
|
$646.69M |
|
81.54M |
|
| Cash Flow Statement Financials | |
$-142.42M |
|
$-389.75M |
|
$591.00M |
|
$114.09M |
|
$172.92M |
|
$58.83M |
|
$19.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
43.76 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-142.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-4.98% |
|
-4.98% |
|
-4.87% |
|
-4.98% |
|
$7.93 |
|
$-2.11 |
|
$-2.10 |
|